Lotus Eye Hospital & Institute Ltd.
BSE: 532998 | Sector: Health care |
NSE: LOTUSEYE | ISIN Code: INE947I01017 |
BSE 14:15 | 01 Feb | 72.30 |
2.00 (2.84%) |
OPEN
71.95 |
HIGH
72.75 |
LOW
68.00 |
NSE 14:07 | 01 Feb | 70.00 |
0.25 (0.36%) |
OPEN
71.55 |
HIGH
72.80 |
LOW
69.00 |
OPEN | 71.95 |
PREVIOUS CLOSE | 70.30 |
VOLUME | 1047 |
52-Week high | 96.90 |
52-Week low | 42.05 |
P/E | 35.79 |
Mkt Cap.(Rs cr) | 150 |
Buy Price | 69.05 |
Buy Qty | 79.00 |
Sell Price | 71.50 |
Sell Qty | 50.00 |
Lotus Eye Hospital & Institute Ltd. (LOTUSEYE) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 1005.50 | -2.85 | 1071.90 | 789.75 | 241249.61 |
Divi's Lab. | 3328.10 | 0.32 | 4640.95 | 3197.00 | 88344.41 |
Cipla | 1024.00 | 0.69 | 1185.20 | 880.00 | 82652.16 |
Dr Reddy's Labs | 4326.85 | 0.07 | 4645.55 | 3655.00 | 72050.71 |
Apollo Hospitals | 4260.35 | 0.11 | 5015.45 | 3365.90 | 61255.31 |
Torrent Pharma. | 1517.90 | -0.23 | 1722.70 | 1242.50 | 51371.81 |
Zydus Lifesci. | 437.05 | 1.46 | 458.60 | 319.40 | 44238.20 |
Abbott India | 20801.00 | -0.20 | 22481.80 | 15525.00 | 44202.12 |
Max Healthcare | 435.25 | -1.33 | 482.50 | 306.00 | 42255.81 |
Alkem Lab | 3032.75 | 0.76 | 3720.00 | 2835.00 | 36256.53 |
Lupin | 738.75 | 0.11 | 922.50 | 583.05 | 33605.74 |
Biocon | 239.40 | 1.83 | 410.50 | 229.70 | 28742.36 |
Aurobindo Pharma | 414.00 | 1.40 | 730.00 | 407.15 | 24256.26 |
Syngene Intl. | 567.55 | 0.68 | 682.25 | 508.10 | 22783.16 |
Ipca Labs. | 853.10 | 0.35 | 1089.00 | 830.00 | 21643.15 |
Glaxosmi. Pharma | 1254.15 | 0.60 | 1734.90 | 1242.00 | 21246.56 |
Fortis Health. | 279.40 | -0.89 | 324.80 | 219.80 | 21093.58 |
Gland Pharma | 1265.90 | -2.64 | 3599.00 | 1264.90 | 20849.37 |
Laurus Labs | 334.75 | 1.32 | 626.00 | 324.25 | 18031.31 |
Pfizer | 3857.25 | -0.38 | 4800.00 | 3851.15 | 17646.92 |
Quick Links for Lotus Eye Hospital & Institute:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices